Stay updated on Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial page.

Latest updates to the Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Melanoma and related topic links (MedlinePlus Genetics) and a consolidated Locations section including California, New Jersey, New York, and Pennsylvania. Removed the separate state location subsections (California Locations, New Jersey Locations, New York Locations, Pennsylvania Locations) and updated the page revision to v3.3.3.SummaryDifference0.7%

- Check20 days agoChange DetectedThe Melanoma topic and the MedlinePlus Genetics related topics were removed from the page.SummaryDifference0.2%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedMelanoma-related topics and MedlinePlus Genetics links were added, and publication attribution language from PubMed was updated; these changes are editorial and do not affect study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check48 days agoChange DetectedThe general banner about government funding and potential delays has been removed from the page; the study details and related links remain visible and accessible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check56 days agoChange DetectedThe page no longer lists 'Melanoma' as a related topic and removes the 'MedlinePlus Genetics' related topic.SummaryDifference0.2%

- Check63 days agoChange DetectedThe two screenshots show minor formatting and layout adjustments on the Study Details page without any updates to core trial information such as the title, interventions, eligibility criteria, primary outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial page.